TREPROSTINIL TEVA 10 MGML

国家: 以色列

语言: 英文

来源: Ministry of Health

现在购买

下载 公众评估报告 (PAR)
29-07-2021

有效成分:

TREPROSTINIL AS SODIUM

可用日期:

ABIC MARKETING LTD, ISRAEL

ATC代码:

B01AC21

药物剂型:

SOLUTION FOR INFUSION

组成:

TREPROSTINIL AS SODIUM 10 MG/ML

给药途径:

S.C, I.V

处方类型:

Not required

厂商:

TEVA PHARMACEUTICAL INDUSTRIES LTD, ISRAEL

治疗领域:

TREPROSTINIL

疗效迹象:

Treprostinil Teva is indicated for the treatment of:- Primary pulmonary arterial hypertension - Pulmonary arterial hypertension associated with connective tissue disorders.- Pulmonary hypertension associated with congenital systemic to pulmonary shunts.

授权日期:

2020-11-29

其他语言的文件

资料单张 资料单张 希伯来文 29-07-2021

搜索与此产品相关的警报